UPDATE: Goldman Sachs Downgrades 10X Genomics (TXG) to Sell
- S&P 500 closes higher to secure strongest Q1 since 2019
- UBS sees 5 warnings signals on semiconductor chip stocks
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- Reddit (RDDT) stock continues to slide as short-sellers eye stock
- Estée Lauder (EL) climbs as BofA upgrades to Buy on profit recovery expectations
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- AMC Entertainment (AMC) Enters $250M ATM Agreement
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Home Depot (HD) to Acquire SRS Distribution for $18.25B EV
10x Genomics Offerings Not Yet Big Enough to Offset Core Business Deceleration - GS
August 18, 2022 3:21 PM EDTGoldman Sachs analyst Matthew Sykes downgraded shares of 10x Genomics (NASDAQ: TXG) to Sell from Neutral in a note Thursday, lowering the price target to $35 from $55.
The analyst said they expect a "materially slower cadence" to the company's 2023/24 sales growth rate vs consensus (and historically) as it transitions to a... More